Nerve growth factor and the neurotrophic factor hypothesis

Brain and Development

Volumn 18, Issue 5, 1996, Pages 362-368

  Yuen, Eric C ^a   Howe, Charles L ^a   Li, Yiwen ^a   Holtzman, David M ^a,c   Mobley, William C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Nerve growth factor; Neurotrophic factor hypothesis; Neurotrophin

Indexed keywords

NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIC FACTOR;

CAUDATE NUCLEUS; CELL SIZE; CELL SURVIVAL; CHOLINERGIC NERVE CELL; FOREBRAIN; HYPOTHESIS; NERVE CELL DIFFERENTIATION; NEUROCHEMISTRY; PROTEIN EXPRESSION; PUTAMEN; REVIEW;

EID: 0030248402     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/0387-7604(96)00051-4     Document Type: Review

References (63)

1. 1. Longo FM, Holtzman DM, Grimes ML, Mobley WC. Nerve growth factor: actions in the peripheral and central nervous systems. In: Fallon J, Loughlin S, eds. Neurotrophic factors. New York: Academic Press, 1993: 209-56.
2. 2. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 1995; 18: 223-53.
3. 3. Yuen EC, Mobley WC. Therapeutic applications of neurotrophic factors in disorders of motor neurons and peripheral nerves. Mol Med Today 1995; 1: 278-86.
4. 4. Hamburger V, Levi-Montalcini R. Proliferation, differentiation and degeneration on the spinal ganglia of the chick embryo under normal and experimental conditions. J Exp Zool 1949; 111: 457.
5. 5. Levi-Montalcini R, Hamburger V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J. Exp. Zool. 1951; 116: 321-62.
6. 6. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987; 237: 1154-61.
7. 7. Levi-Montalcini R, Hamburger V. A diffusible agent of mouse sarcoma, producing hyperplasia of sympathetic ganglia and hyperneurotization of viscera in the chick embryo. J Exp Zool 1953; 123: 233-88.
8. 8. Cohen S, Levi-Montalcini R. A nerve growth-stimulating factor isolated from snake venom. Proc Natl Acad Sci USA 1956; 42: 571-4.
9. 9. Cohen S. Purification of a nerve-growth promoting protein from the mouse salivary gland and its neuro-cytotoxic antiserum. Proc Natl Acad Sci USA 1960; 46: 302-11.
10. 10. Schecterson LC, Bothwell M. Novel roles for neurotrophins are suggested by BDNF and NT-3 mRNA expression in developing neurons. Neuron 1992; 9: 449-63.
11. 11. Acheson A, Conover JC, Fandl JP, et al. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 1995; 374: 450-3.
12. 12. Phillips HS, Hains JM, Laramee GR, et al. Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons. Science 1990; 250: 290-4.
13. 13. Merlio JP, Ernfors P, Jaber M, Persson H. Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience 1992; 51: 513-32.
14. 14. Barbacid M. The Trk family of neurotrophin receptors. J Neurobiol 1994; 25: 1386-403.
15. 15. Alderson RF, Alterman AL, Barde YA, Lindsay RM. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron 1990; 5: 297-306.
16. 16. Holtzman DM, Kilbridge J, Li Y, et al. TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons. J Neurosci 1995; 15: 1567-76.
17. 17. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995; 270: 593-8.
18. 18. DiCicco-Bloom E, Friedman WJ, Black IB. NT-3 stimulates sympathetic neuroblast proliferation by promoting precursor survival. Neuron 1993; 11: 1101-11.
19. 19. Verdi JM, Anderson DJ. Neurotrophins regulate sequential changes in neurotrophin receptor expression by sympathetic neuroblasts. Neuron 1994; 13: 1359-72.
20. 20. Maffei L, Berardi N. Domenici L. et al. Nerve growth factor (NGF) prevents the shift in ocular dominance distribution of visual cortical neurons in monocularly deprived rats. J Neurosci 1992; 12: 4651-62.
21. 21. Domenici L, Berardi N, Carmignoto G, et al. Nerve growth factor prevents the amblyopic effects of monocular deprivation. Proc Natl Acad Sci USA 1991; 88: 8811-5.
22. 22. Domenici L, Cellerino A, Maffei L. Monocular deprivation effects in the rat visual cortex and lateral geniculate nucleus are prevented by nerve growth factor (NGF). II. Lateral geniculate nucleus. Proc R Soc Lond B Biol Sci 1993; 251: 25-31.
23. 23. Berardi N, Domenici L, Parisi V, et al. Monocular deprivation effects in the rat visual cortex and lateral geniculate nucleus are prevented by nerve growth factor (NGF). I. Visual cortex. Proc R Soc Land B Biol Sci 1993; 251: 17-23.
24. 24. Carmignoto G, Canella R, Candeo P, et al. Effects of nerve growth factor on neuronal plasticity of the kitten visual cortex. J Physiol (Lond) 1993; 464: 343-60.
25. 25. Fiorentini A, Berardi N, Maffei L. Nerve growth factor preserves behavioral visual acuity in monocularly deprived kittens. Vis Neurosci 1995; 12: 51-5.
26. 26. Domenici L, Cellerino A, Berardi N, et al. Antibodies to nerve growth factor (NGF) prolong the sensitive period for monocular deprivation in the rat. Neuroreport 1994; 5: 2041-4.
27. 27. Berardi N, Cellerino A, Domenici L. et al. Monoclonal antibodies to nerve growth factor affect the postnatal development of the visual system. Proc Natl Acad Sci USA 1994: 91: 684-8.
28. 28. Cabelli RJ, Hohn A, Shatz CJ. Inhibition of ocular dominance column formation by infusion of NT-4/5 or BDNF. Science 1995; 267: 1662-6.
29. 29. Olton D, Markowska A, Voytko ML, et al. Basal forebrain cholinergic system: a functional analysis. Adv Exp Med Biol 1991; 295: 353-72.
30. 30. Korsching S, Auburger G, Heumann R, et al. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J 1985; 4: 1389-93.
31. 31. Shelton DL, Reichardt LF. Studies on the expression of beta NGF gene in the central nervous system: level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several neuronal populations. Proc. Natl. Acad. Sci. USA 1986; 83: 2714-8.
32. 32. Whittemore SR, Ebendal T, Larkfors L, et al. Developmental and regional expression of beta-nerve growth factor messenger RNA and protein in the rat central nervous system. Proc Natl Acad Sci USA 1986; 83: 817-21.
33. 33. Ayer-LeLievre C, Olson L, Ebendal T, et al. Expression of the beta-nerve growth factor gene in hippocampal neurons. Science 1988; 240: 1339-41.
34. 34. Ernfors P, Ibanez CF, Ebendal T, et al. Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci USA 1990; 87: 5454-8.
35. 35. Gnahn H, Hefti F, Heumann R, et al. NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain. Dev Brain Res 1983; 9: 42-52.
36. 36. Mobley WC, Rutkowski JL, Tennekoon GI, et al. Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons. Mol Brain Res 1986; 387: 53-62.
37. 37. Li Y, Holtzman DM, Kromer LF, et al. Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons. J Neurosci 1995; 15: 2888-905.
38. 38. Large TH, Bodary SC, Clegg DO, et al. Nerve growth factor gene expression in the developing rat brain. Science 1986; 234: 352-5.
39. 39. Auburger G, Heumann R, Hellweg R, et al. Developmental changes of nerve growth factor and its mRNA in the rat hippocampus: comparison with choline acetyltransferase. Dev Biol 1987; 120: 322-8.
40. 40. Crowley C, Spencer SD, Nishimura MC, et al. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 1994; 76: 1001-11.
41. 41. Smeyne RJ, Klein R, Schnapp A, et al. Severe sensory and sympathetic neuropathies in mice carrying a disrupted trk/NGF receptor gene. Nature 1994; 368: 246-9.
42. 42. Mobley WC, Rutkowski JL, Tennekoon GI, et al. Choline acetyltransferase activity in striatum of neonatal rats increased by nerve growth factor. Science 1985; 229: 284-7.
43. 43. Mobley WC, Woo JE, Edwards RH, et al. Developmental regulation of nerve growth factor and its receptor in the rat caudate-putamen. Neuron 1989; 3: 655-64.
44. 44. Holtzman DM, Li Y, Chen K, et al. Nerve growth factor reverses neuronal atrophy in a Down syndrome model of age-related neurodegeneration. Neurology 1993; 43: 2668-73.
45. 45. Li Y, Clary DO, Reichardt LF, Mobley WC. Developmentally regulated expression of trkA and ChAT in the rat caudate-putamen. Soc Neurosci Abstr 1995; 21: 2012.
46. 46. Apfel SC, Lipton RB, Arezzo JC, Kessler JA. Nerve growth factor prevents toxic neuropathy in mice. Ann Neurol 1991; 29: 87-90.
47. 47. Apfel SC, Arezzo JC, Lipson L, Kessler JA. Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 1992; 31: 76-80.
48. 48. Diemel LT, Brewster WJ, Fernyhough P, Tomlinson DR. Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor. Brain Res Mol Brain Res 1994; 21: 171-5.
49. 49. Apfel SC, Arezzo JC, Brownlee M, et al. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res 1994; 634: 7-12.
50. 50. Rask C, Apfel S, Adornato B, et al. An overview of the clinical experience with systemic administration of nerve growth factor in treating peripheral nervous system disorders. Ann Neurol 1995; 38: 317.
51. 51. Oppenheim RW, Yin QW, Prevette D, Yan Q. Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature 1992; 360: 755-7.
52. 52. Sendtner M, Holtmann B, Kolbeck R, et al. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 1992; 360: 757-9.
53. 53. Yan Q, Elliott J, Snider WD. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 1992; 360: 753-5.
54. 54. Mitsumoto H, Bradley WG. Murine motor neuron disease (the wobbler mouse): degeneration and regeneration of the lower motor neuron. Brain 1982; 105: 811-34.
55. 55. Mitsumoto H, Ikeda K, Klinkosz B, et al. Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 1994; 265: 1107-10.
56. 56. Ikeda K, Klinkosz B, Greene T, et al. Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol 1995; 37: 505-11.
57. 57. Hory-Lee F, Russell M, Lindsay RM, Frank E. Neurotrophin 3 supports the survival of developing muscle sensory neurons in culture. Proc Natl Acad Sci USA 1993; 90: 2613-7.
58. 58. Hohn A, Leibrock J, Bailey K, Barde YA. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 1990; 344: 339-41.
59. 59. Gao WQ, Dybdal N, Shinsky N, et al. Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann Neurol 1995; 38: 30-7.
60. 60. Elias KA, Shinsky N, Ingle G, et al. Neurotrophin-3 (NT-3) treatment maintains myelinated nerve fiber profiles and prevents A-fiber function loss in diabetic rats. Soc Neurosci Abstr 1995; 21: 1055.
61. 61. Lewis ME, Neff NT, Contreras PC, et al. Insulin-like growth factor-I: potential for treatment of motor neuronal disorders. Exp Neurol 1993; 124: 73-88.
62. 62. Ishii DN, Glazner GW, Pu SF. Role of insulin-like growth factors in peripheral nerve regeneration. Pharmacol Ther 1994; 62: 125-44.
63. 63. Lai EC, Felice K, Festoff BW, et al. A double-blind, placebo controlled study of recombinant human insulin-like growth factor 1 in the treatment of amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 971.